Real-World Study of PADN for the Treatment of PAH
Recruiting · NCT07039604 · Observational (researchers observe without assigning treatment) · Lead sponsor: Pulnovo Medical (Wuxi) Co., Ltd.
View the official record on ClinicalTrials.gov →Interventions studied
Enhancor™ Radiofrequency Catheter, Pulnovo Medical (Wuxi) CO., Ltd., Wuxi, Jiangsu, China
What this trial is about
Real-World Study of PADN for the Treatment of PAH
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diagnosed with PAH and received PADN procedure since March 2024.
- No contraindications to procedure.
- Able to provide informed consent and authorize use of health/research data.
- Compliant with treatment and follow-up requirements.
Exclusion criteria
- None specified.
Where it is running
1 location listed.
- The First Affiliated Hospital with Nanjing Medical University - Nanjing, Jiangsu, China